SH2 Domain Containing 4A (SH2D4A) Antibody
416€ (200 µl)
Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
935106861
info@markelab.com
name
SH2 Domain Containing 4A (SH2D4A) Antibody
category
Primary Antibodies
provider
Abbexa
reference
abx433269
tested applications
P-ELISA, WB
Description
SH2D4A Antibody is a Goat Polyclonal antibody against SH2D4A.
Documents del producto
Instrucciones
Data sheet
Product specifications
| Category | Primary Antibodies |
| Immunogen Target | SH2 Domain Containing 4A (SH2D4A) |
| Host | Goat |
| Reactivity | Human |
| Recommended Dilution | P-ELISA: 1/1000. Optimal dilutions/concentrations should be determined by the end user. |
| Clonality | Polyclonal |
| Conjugation | Unconjugated |
| Isotype | IgG |
| Purification | Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide. |
| Size 1 | 200 µl |
| Form | Liquid |
| Tested Applications | P-ELISA, WB |
| Buffer | Tris saline, pH 7.3, containing 0.02% sodium azide and 0.5% bovine serum albumin. |
| Availability | Shipped within 5-10 working days. |
| Storage | Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles. |
| Dry Ice | No |
| Gene ID | 63898 |
| NCBI Accession | NP_071354.2 |
| Alias | PPP1R38, SH2A |
| Background | Antibody anti-SH2D4A |
| Status | RUO |
| Note | Concentration: 0.5 mg/ml - |
Descripción
SH2D4A is an SH2 domain-containing protein that functions as a negative regulator of signaling pathways activated by receptor tyrosine kinases and cytokine receptors. It interacts with signaling molecules like STAT proteins and phosphatases to inhibit downstream pathways such as JAK/STAT and MAPK, modulating processes like cell proliferation, differentiation, and immune responses. SH2D4A is predominantly expressed in immune cells and tissues involved in hematopoiesis, where it plays a role in regulating cytokine signaling and immune homeostasis. It functions as a tumor suppressor in certain contexts, inhibiting excessive proliferation and survival signaling. Dysregulation or loss of SH2D4A has been linked to cancer progression and immune disorders due to uncontrolled activation of cytokine signaling. Knockout studies reveal hyperactive immune responses, abnormal proliferation, and defects in cytokine regulation, emphasizing its role as a critical negative regulator of cellular signaling pathways.
Related Products
SH2D4A antibody
Inhibits estrogen-induced cell proliferation by competing with PLCG for binding to ESR1, blocking the effect of estrogen on PLCG and repressing estrogen-induced proliferation. May play a role in T-cell development and function.
Ver Producto
Sh2 Domain Containing 4A (SH2D4A) Antibody
Sh2 Domain Containing 4A Antibody is a Rabbit Polyclonal antibody against Sh2 Domain Containing 4A.
Ver Producto
SH2 Domain Containing 4A (SH2D4A) Antibody
SH2D4A Antibody is a Rabbit Polyclonal against SH2D4A.
Ver Producto